Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells

Anticancer Research

Volumn 17, Issue 6 D, 1997, Pages 4259-4268

  Li, Tieli ^a   Harada, Mamoru ^a   Tamada, Koji ^a   Abe, Koichiro ^a   Nomoto, Kikuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Antitumor T cells; CD4+ T cells; Stress; Th1 type cytokines

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CORTICOSTERONE; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 2; MONOCLONAL ANTIBODY; POLYINOSINIC POLYCYTIDYLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CYTOTOXIC T LYMPHOCYTE; ELECTRIC POTENTIAL; FEMALE; HELPER CELL; IMMOBILIZATION STRESS; MELANOMA B16; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; DEXAMETHASONE; FEMALE; IMMUNE TOLERANCE; INTERFERON INDUCERS; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; KILLER CELLS, NATURAL; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; POLY I-C; RESTRAINT, PHYSICAL; SPLEEN; STRESS, PSYCHOLOGICAL; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; TIME FACTORS;

EID: 0031409251     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Schleifer SJ, keller SE, Camerious M, Thomton JC, and Stein M: Suppression of lymphocyte stimulation following bereavement. J A M A 250: 374-377, 1983.
2. Keller SE, Weiss JM, Schleifer SJ, Miller NE, and Stein M: Stress-induced suppression of immunity in adrenalectomized rats. Science 221: 1301-1304, 1983.
3. Dhabhar FS, Miller AH, McEwen BS, and Spencer RL: Stress-induced changes in blood leukocyte distribution: role of drenal steroid hormones. J Immunol 157: 1638-1644, 1996.
4. Dhabhar FS, Miller AH, McEwen BS, and Spetncer RL: Effects of stress on immune cell distribution: dynamics and hormonal mechanisms. J Immunol 154: 5511-5527, 1995.
5. ∼a viral infection: effects of restraint stress-induced elevation in endogeneous corticosterone. J Immunol 157: 1870-1877, 1996.
6. Ben-Eliyahu S, Ylrmiya R, Liebeskind JC, Taylor AN, and Gale RP: Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation of the immune system. Brain Behavior Immunity 5: 193-205, 1991.
7. Bonneau RH, Sheridan JF, Feng N, and Glaser R: Stress-induced suppression of herpes simplex virus (HSV)-specific cytotoxic T lymphocyte and natural killer activity and enhancement of acute pathogenesis following local HSV infection. Brain Behavior Immunity 5: 170-192, 1991.
8. Kandil O, and Borysenko M: Stress-induced decline in immune responsiveness in C3H/HeJ mice: relation to endocrine alternations and tumor growth. Brain Behavior Immunity 2: 32-49, 1988.
9. Riley V: Psychoneuroendocrine influences on immunocompetence and neoplasia. Science 212: 110-1109, 1981.
10. Eysenck HJ: Personality, stress and cancer: Prediction and prophylaxis. Br J Med Psychol 61: 57-75, 1988.
11. Lewy S, Herberman R, Lippman M, and d'Angelo T: Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast camcer. J Clin Oncol 5: 348-353, 1987.
12. Temosock L: Personality, coping style, emotion and cancer: Towards an integrative model. Cancer Surv 6: 545-565, 1987.
13. Cassileth BR, Lusk EJ, Miller DS, Brown LL, and Miller C: Psychosocial correlates of survival in advanced malignant disease? N Engl J Med 312: 1551-1555, 1985.
14. Dekrey GK, and Kerkvliet NI: Effects of exogeneous corticosterone treatment on alloantigen-specific cytotoxic T lymphocyte activity in mice. J Pharmacology Experimental Therapeutics 273: 823-829, 1995.
15. Gillis S, Crabtree GR, and Smith KA: Glucocorticoid-induced inhibition of T cell growth factor production. II. The effect on the in vitro generation of cytotoxic T cells. J Immunol 123: 1632-1638, 1979.
16. Harada M, Okamoto T, Omoto K, Tamada K, Takenoyama M, Hirashima C, Ito O, Kimura G, and Nomoto K: Specific immunotherapy with tumour-draining lymph node cells cultured with both anti-CD3 and anti-CD28 monoclonal antibodies. Immunology 87: 447-453, 1996.
17. Fearon ER, Pardoll DM, Itaya T, Golumbek P, Levitsky HI, Simons JI, Karasuyama H, Vogelstein B, and Forest P: Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antiutmor response. Cell 60: 397-403, 1990.
18. Guery JC, Galbiati F, Smiroldo S, and Adorini L: Selective development of T helper (Th) 2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice. J Exp Med 183: 485-497, 1996.
19. Duncan DD, and Swain SL: Role of antigen-presenting cells in the polarilized development of helper T cell subsets: evidence for differential cytokine production by Th0 cells in response to antigen presentation by B cells and macrophages. Eur J Immunol 24: 2506-2514, 1994.
20. Thompson CB: Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation ? Cell 81: 979-982, 1995.
21. Rook GAW, Hernandez-Pando R, and Lightman SL: Hromones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol Today 15: 301-303, 1994.
22. Arya SK, Wong-Staal F, and Gallo RC: Dexamethasone-mediated inhibition of human T cell growth factor and γ-interferon messenger RNA. J Immunol 133: 273-276, 1984.
23. Vacca A, Felli MP, Farina AR, Martinotti S, Maroder M, Screpanti I, Meco D, Petrangeli E, Frati L, and Gulino A: Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperative between nuclear factor of activated T cells and AP-1 enhancer elements. J Exp Med 175: 637-646, 1992.
24. Zubiaga AM, Munoz E, and Huber BT: IL-4 and IL-2 selectively rescue Th cell subsets from glucocoticoid-induced apoptosis. J Immunol 149: 107-112, 1992.
25. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, and Coffmann RL: Two types of murine helper Y cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348-2357, 1986.
26. + T cells as Th1 cells based on lymphokine secretion and functional properties. J Immunol 144: 4898-4905, 1990.
27. + T-cells show antitumor activity against sygneneic fibrosarcoma. Cancer Res 53: 106-111, 1993.
28. Okamoto T, Harada M, Tamada K, Yoshida H, Ito O, Kong YY, Takenoyama M, Hirashima C, Matsuzaki G, Nomoto K: Local injection of Ok432 can augment the Th1-type T-cell response in tumor-draining lymph node cells and increase their immunotherapeutical potential. Int J Cancer 70: 598-605, 1997.
29. Cox WI, Halbrook NJ, and Friedman H: Mechanisu of glucocorticoid action on murine natural killer cell activity. J Natl Cancer Inst 71: 973-981, 1983.
30. Hochman PS, and Cudkowicz G: Suppression of natural cytotoxicity by spllen cells of hydrocortisone-treated mice. J Immunol 123: 968-976, 1978.
31. Mizobe K, Kishihara K, El-Naggar RED, Madkour GA, Kubo C, and Nomoto K: Restraint stress-induced elevation of endogeneous glucocorticoid suppresses migration of granulocytes and macrophages to an inflamatory locus. J Neuroimmunology 73: 81-98, 1997.
32. Kurosawa S, Harada M, Matsuzaki G, Shinomiya Y, Terao H, Kobayashi N, and Nomoto K: Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes. Immunology 85: 338-346, 1995.
33. Kurosawa S, Harada M, Shinimiya Y, Terao H, and Nomoto K: The concurrent administration of OK432 augments the antitumor vaccination effect with tumor cells by sustaining locally infiltrating natural killer cells. Cancer Immunol Immunother 43: 31-38, 1996.